Research Overview
Bacteriostatic Water is a USP-grade sterile diluent supplied in a 10ml vial and formulated with 0.9% benzyl alcohol in sterile water for injection. It is a research supply, not a peptide, and is the most commonly cited diluent in published methodology for reconstituting lyophilised research peptides such as BPC-157, TB-500, GHK-Cu, Kisspeptin-10, PT-141, oxytocin and the wider catalogue of research peptides.
The 0.9% benzyl alcohol concentration serves as a bacteriostatic preservative, permitting multiple withdrawals from a single vial across the working stability window characterised by the supplier and laboratory's QC programme. The product is supplied with batch-specific documentation including sterility and endotoxin testing where applicable. It is intended exclusively for in-vitro and laboratory research use and is not authorised as a drug, food or cosmetic.
Mechanism Studied in Research
Benzyl alcohol is included in Bacteriostatic Water at 0.9% as a bacteriostatic preservative, characterised in published pharmacopoeial monographs as inhibiting bacterial growth without being fully bactericidal. Its mechanism involves disruption of bacterial membrane integrity and interference with cellular metabolism.
In peptide-research workflows, the diluent is primarily used as a reconstitution medium rather than an active experimental compound. Researchers utilise it to prepare defined peptide concentrations while allowing repeated withdrawals from a single vial during laboratory protocols.
The solution is frequently referenced in published peptide methodology because it provides practical handling benefits compared with preservative-free water when repeated access to the vial is required.
Research Applications
Bacteriostatic Water is used across the majority of peptide-research workflows as the principal reconstitution diluent for lyophilised research materials. Standard reconstitution volumes vary according to vial size and target working concentration.
Researchers use it when preparing peptide stocks for cell-culture work, analytical validation studies, receptor-signalling experiments and laboratory assay development. The diluent is also referenced in HPLC sample preparation, mass-spectrometry validation and stability-indicating studies involving lyophilised peptides.
Because the formulation contains a bacteriostatic preservative, it is frequently selected where multiple withdrawals from the same vial are anticipated during an active research protocol.
Reconstitution Reference
Bacteriostatic Water is supplied ready for use and requires no reconstitution. Researchers draw the desired volume from the vial using a sterile syringe and aseptic technique.
When used for peptide preparation, the diluent is introduced slowly down the inner wall of the peptide vial without directing the stream onto the lyophilised cake. After addition, the peptide vial is left to dissolve passively for several minutes before gentle inversion if required.
The solution should remain clear and free of visible particulate matter throughout use.
Storage and Handling
Unopened Bacteriostatic Water vials should be stored at room temperature in a dry, light-protected environment. Once opened, good laboratory practice recommends refrigeration between 2 and 8 degrees Celsius and use within the supplier’s recommended stability period.
Researchers should maintain aseptic handling procedures during all withdrawals. The vial should not be used if the solution appears cloudy, discoloured or if the integrity of the stopper has been compromised.
All handling procedures should be documented according to laboratory record-keeping requirements.
References
[2] Pharmaceutical Compounding Sterile Preparation Standards.
[3] Sterile Water and Preservative Systems in Laboratory Research.
[4] Stability and Handling of Multi-Dose Injectable Preparations.